Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 4 min ago

Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations

Wed, 07/27/2016 - 17:23
SAN DIEGO, July 27, 2016 -- (Healthcare Sales & Marketing Network) -- Biocept, Inc. (BIOC), a molecular diagnostics company commercializing and developing biomarkers to improve the detection and treatment of cancer, announces the appointment of Timothy C....
Diagnostics, Oncology, Personnel
Biocept, liquid biopsy

FloShield Significantly Reduces Robotic Laparoscope Lens Removals During Surgery

Wed, 07/27/2016 - 17:20
COLUMBUS, OH--(Healthcare Sales & Marketing Network) - FloShield®, a clear sheath that mounts over a laparoscope and creates a vortex barrier of CO2 in front of the lens, showed a statistically significant reduction in robotic laparoscope lens removals...
Devices, Surgery
Minimally Invasive Devices, FloShield, laparoscope, laparoscopy

Coverage of INSIGHTEC's Exablate for Pain Palliation of Bone Metastases Expands to 99.8 Million Members in the US

Wed, 07/27/2016 - 17:16
HAIFA, Israel, July 27, 2016 -- (Healthcare Sales & Marketing Network) -- INSIGHTEC, the world leader in non-invasive MR-guided Focused Ultrasound (MRgFUS) technology, announced today that Exablate for pain palliation of bone metastases in cancer patients...
Devices, Oncology, Reimbursement
INSIGHTEC, Exablate, bone metastases

LabCorp Announces Agreement to Acquire Sequenom

Wed, 07/27/2016 - 17:12
BURLINGTON, N.C. & SAN DIEGO--(Healthcare Sales & Marketing Network)--Laboratory Corporation of America® Holdings (LabCorp®) (LH), the world’s leading healthcare diagnostics company, and Sequenom, Inc. (SQNM), a pioneer in non-invasive prenatal tes...
Diagnostics, Mergers & Acquisitions
Laboratory Corporation of America, LabCorp, Sequenom, prenatal testing

John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor

Wed, 07/27/2016 - 17:10
INDIANAPOLIS, July 27, 2016 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) today announced that John C. Lechleiter, Ph.D., chairman, president and chief executive officer, will retire as president and CEO and from the company eff...
Biopharmaceuticals, Personnel
Eli Lilly

Carl Zeiss Meditec Recruits James V. Mazzo to Lead its Newly Consolidated Ophthalmology Organization

Wed, 07/27/2016 - 17:08
JENA, GERMANY - (Healthcare Sales & Marketing Network) - Carl Zeiss Meditec AG has been expanding its ophthalmology business over the last years. Today, it has the broadest line of diagnostic and surgical products in the industry. Consolidating the product...
Devices, Ophthalmology, Personnel
Carl Zeiss Meditec

Pernix Therapeutics Announces Reorganization of Senior Management Team

Wed, 07/27/2016 - 16:22
John Sedor Appointed CEO on a Permanent Basis Company Names Pharmaceutical Industry Veteran, Dr. Graham Miao, as President & CFO Company Positioned to Maximize Value and Drive Revenue Growth and Profitability MORRISTOWN, N.J., July 26, 2016 -- (H...
Biopharmaceuticals, Personnel
Pernix Therapeutics, Zohydro, Treximet, Silenor

Alphatec Holdings Announces Sale of International Business to Globus Medical

Tue, 07/26/2016 - 20:51
Cash proceeds of $80 million to substantially reduce Company's outstanding debt, allow for continued investment in commercialization and expansion of U.S. business CARLSBAD, Calif., July 26, 2016 -- (Healthcare Sales & Marketing Network) -- Alphatec Hol...
Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions
Alphatec Spine, Globus Medical

Cynosure Receives Approval to Market SculpSure(R) in South Korea

Tue, 07/26/2016 - 15:21
WESTFORD, Mass., July 26, 2016 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO) today announced that it has received approval from the Korean Ministry of Food and Drug Safety (MFDS) to market SculpSure® for non-invasive lipolysis of ...
Devices, Dermatology, Regulatory
Cynosure, SculpSure

NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma

Tue, 07/26/2016 - 15:17
ST. HELIER, Jersey--(Healthcare Sales & Marketing Network)--Novocure (NVCR) announced today that the National Comprehensive Cancer Network (NCCN) has recommended Optune as a standard treatment option for newly diagnosed glioblastoma (GBM) in its Clinical P...
Devices, Oncology
Novocure, Tumor Treating Fields, Optune, glioblastoma, NCCN

Janssen Announces Clinical Collaboration with Bristol-Myers Squibb to Evaluate Immuno-oncology Combination in Lung Cancer

Tue, 07/26/2016 - 15:14
RARITAN, N.J., July 26, 2016 -- (Healthcare Sales & Marketing Network) -- Janssen Biotech, Inc. announced today it has entered into a clinical study collaboration agreement with Bristol-Myers Squibb Company to evaluate the combination of two immuno-oncolo...
Biopharmaceuticals, Oncology
Janssen, Bristol-Myers Squibb, OPDIVO, nivolumab, NSCLC

Zimmer Biomet Unveils Signature Solutions(TM)

Tue, 07/26/2016 - 15:12
WARSAW, Ind., July 26, 2016 -- (Healthcare Sales & Marketing Network) -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today unveiled Signature Solutions™, a comprehensive suite of clinical services and t...
Devices, Orthopaedic, Product Launch
Zimmer Biomet, Signature Solutions

Inivata Adds to Board of Directors With Appointment of Peter Wrighton-Smith

Tue, 07/26/2016 - 15:09
CAMBRIDGE, England, July 26, 2016 -- (Healthcare Sales & Marketing Network) -- Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised healthcare in oncology, has appoin...
Diagnostics, Personalized Medicine, Oncology, Personnel
Inivata, circulating tumour DNA

Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter

Tue, 07/26/2016 - 13:27
MADISON, Wis., July 26, 2016 -- (Healthcare Sales & Marketing Network) -- Exact Sciences Corp. (EXAS) today announced that the company generated revenues of $21.2 million during the second quarter ended June 30, 2016, representing a 161-percent increase f...
Diagnostics, Oncology
EXACT SCIENCES, Cologuard, colorectal cancer

CellMax Life Raises $14M in Venture Funding, Launches Precision Cancer Testing Company for Early Detection and Optimal Management of Cancer

Tue, 07/26/2016 - 13:21
SUNNYVALE, Calif.--(Healthcare Sales & Marketing Network)--CellMax Life, Inc. today announced $9M in series A-1 venture funding, and formally introduced itself as a precision cancer blood-testing company providing comprehensive, personalized multi-biomarke...
Diagnostics, Personalized Medicine, Venture Capital
CellMax Life, CellMax CRC-Protect

AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR(TM) (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C

Tue, 07/26/2016 - 13:13
NORTH CHICAGO, Ill., July 25, 2016 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for VIEKIRA XR™ (...
Biopharmaceuticals, FDA
AbbVie, VIEKIRA XR, VIEKIRA PAK, hepatitis C

QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment

Mon, 07/25/2016 - 15:41
SINGAPORE, July 25, 2016 -- (Healthcare Sales & Marketing Network) -- QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), is a global company eng...
Devices, Interventional, Cardiology, Litigation
QT Vascular, AngioScore, Spectranetics, PTCA, balloon catheter

Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever

Mon, 07/25/2016 - 15:37
GALWAY, Ireland--(Healthcare Sales & Marketing Network)--Neuravi, a company dedicated to improving clinical outcomes for stroke patients, today announced that Robert Colloton has joined the company’s senior management team as vice president of U.S. Sales a...
Devices, Interventional, Neurology, Personnel
Neuravi, EmboTrap, Revascularization, stroke

MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo

Mon, 07/25/2016 - 15:34
MARIETTA, Ga., July 25, 2016 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and thera...
Devices, Regenerative Medicine, Product Launch
MiMedx, OrthoFlo

TSO3 Simplifies Sterilization of Complete Heavy-Duty, Battery-Powered Orthopedic Instrument Sets

Mon, 07/25/2016 - 15:30
Company Offers Single-Cycle Solution that can Replace Steam and Legacy Low-Temperature Sterilization Practices QUÉBEC CITY, July 25, 2016 -- (Healthcare Sales & Marketing Network) - TSO3 Inc. (TOS.TO) ("TSO3" or the "Company"...
Devices, Surgery
TSO3, STERIZONE, hydrogen peroxide, ozone, sterilization

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong